Skip to main content
Premium Trial:

Request an Annual Quote

10x Genomics Prices Upsized $440M Public Offering

NEW YORK – Single-cell and spatial molecular analysis firm 10x Genomics announced on Friday the pricing of an upsized underwritten public offering of Class A common stock at $110 per share, before underwriting discounts and commissions.

The Pleasanton, California-based firm is now offering 4 million shares, plus an option for the underwriters to purchase an additional 600,000 shares at the public offering price. Initially, the company said it planned to offer 3.5 million shares plus an underwriters' option of 500,000 shares. The firm expects the offering to close on Sept. 15, 2020.

JP Morgan, Bank of America, and Cowen and Company are underwriters for the offering. Stifel and William Blair are acting as co-managers.

The firm went public a year ago, raising $410.8 million in net proceeds.

In Friday morning trade on the Nasdaq, shares of 10x Genomics were up nearly 3 percent at $116.75.